Literature DB >> 22836527

Metabolic control analysis of cellular respiration in situ in intraoperational samples of human breast cancer.

Tuuli Kaambre1, Vladimir Chekulayev, Igor Shevchuk, Minna Karu-Varikmaa, Natalja Timohhina, Kersti Tepp, Jelena Bogovskaja, Riina Kütner, Vahur Valvere, Valdur Saks.   

Abstract

The aim of this study was to analyze quantitatively cellular respiration in intraoperational tissue samples taken from human breast cancer (BC) patients. We used oxygraphy and the permeabilized cell techniques in combination with Metabolic Control Analysis (MCA) to measure a corresponding flux control coefficient (FCC). The activity of all components of ATP synthasome, and respiratory chain complexes was found to be significantly increased in human BC cells in situ as compared to the adjacent control tissue. FCC(s) were determined upon direct activation of respiration with exogenously-added ADP and by titrating the complexes with their specific inhibitors to stepwise decrease their activity. MCA showed very high sensitivity of all complexes and carriers studied in human BC cells to inhibition as compared to mitochondria in normal oxidative tissues. The sum of FCC(s) for all ATP synthasome and respiratory chain components was found to be around 4, and the value exceeded significantly that for normal tissue (close to 1). In BC cells, the key sites of the regulation of respiration are Complex IV (FCC = 0.74), ATP synthase (FCC = 0.61), and phosphate carrier (FCC = 0.60); these FCC(s) exceed considerably (~10-fold) those for normal oxidative tissues. In human BC cells, the outer mitochondrial membrane is characterized by an increased permeability towards adenine nucleotides, the mean value of the apparent K(m) for ADP being equal to 114.8 ± 13.6 μM. Our data support the two-compartment hypothesis of tumor metabolism, the high sum of FCC(s) showing structural and functional organization of mitochondrial respiratory chain and ATP synthasome as supercomplexes in human BC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22836527     DOI: 10.1007/s10863-012-9457-9

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  120 in total

1.  On respiratory impairment in cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-08-10       Impact factor: 47.728

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

3.  Elevation of cyclic AMP causes an imbalance between NF-kappaB and p53 in NALM-6 cells treated by doxorubicin.

Authors:  Majid Safa; Hamid Zand; Kazem Mousavizadeh; Ahmad Kazemi; Masoumeh Bakhshayesh; Parisa Hayat
Journal:  FEBS Lett       Date:  2010-07-15       Impact factor: 4.124

Review 4.  Metabolic control analysis indicates a change of strategy in the treatment of cancer.

Authors:  Rafael Moreno-Sánchez; Emma Saavedra; Sara Rodríguez-Enríquez; Juan Carlos Gallardo-Pérez; Héctor Quezada; Hans V Westerhoff
Journal:  Mitochondrion       Date:  2010-06-25       Impact factor: 4.160

5.  Mathematical models of metabolic systems: general principles and control of glycolysis and membrane transport in erythrocytes.

Authors:  R Heinrich
Journal:  Biomed Biochim Acta       Date:  1985

6.  Evidence for a stromal-epithelial "lactate shuttle" in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts.

Authors:  Diana Whitaker-Menezes; Ubaldo E Martinez-Outschoorn; Zhao Lin; Adam Ertel; Neal Flomenberg; Agnieszka K Witkiewicz; Ruth C Birbe; Anthony Howell; Stephanos Pavlides; Ricardo Gandara; Richard G Pestell; Federica Sotgia; Nancy J Philp; Michael P Lisanti
Journal:  Cell Cycle       Date:  2011-06-01       Impact factor: 4.534

7.  Mitochondria-cytoskeleton interaction: distribution of β-tubulins in cardiomyocytes and HL-1 cells.

Authors:  Rita Guzun; Minna Karu-Varikmaa; Marcela Gonzalez-Granillo; Andrey V Kuznetsov; Lauriane Michel; Cécile Cottet-Rousselle; Merle Saaremäe; Tuuli Kaambre; Madis Metsis; Michael Grimm; Charles Auffray; Valdur Saks
Journal:  Biochim Biophys Acta       Date:  2011-02-04

8.  GLUT1 expression in human breast carcinoma: correlation with known prognostic markers.

Authors:  M Younes; R W Brown; D R Mody; L Fernandez; R Laucirica
Journal:  Anticancer Res       Date:  1995 Nov-Dec       Impact factor: 2.480

9.  Isozyme patterns of normal, benign, and malignant human breast tissues.

Authors:  D Balinsky; C E Platz; J W Lewis
Journal:  Cancer Res       Date:  1983-12       Impact factor: 12.701

10.  Contributions of cell metabolism and H+ diffusion to the acidic pH of tumors.

Authors:  Paul A Schornack; Robert J Gillies
Journal:  Neoplasia       Date:  2003 Mar-Apr       Impact factor: 5.715

View more
  21 in total

1.  Comparative analysis of some aspects of mitochondrial metabolism in differentiated and undifferentiated neuroblastoma cells.

Authors:  Aleksandr Klepinin; Vladimir Chekulayev; Natalja Timohhina; Igor Shevchuk; Kersti Tepp; Andrus Kaldma; Andre Koit; Valdur Saks; Tuuli Kaambre
Journal:  J Bioenerg Biomembr       Date:  2013-09-27       Impact factor: 2.945

2.  Tumor microenvironment promotes dicarboxylic acid carrier-mediated transport of succinate to fuel prostate cancer mitochondria.

Authors:  Aigul Zhunussova; Bhaswati Sen; Leah Friedman; Sultan Tuleukhanov; Ari D Brooks; Richard Sensenig; Zulfiya Orynbayeva
Journal:  Am J Cancer Res       Date:  2015-04-15       Impact factor: 6.166

3.  Simple oxygraphic analysis for the presence of adenylate kinase 1 and 2 in normal and tumor cells.

Authors:  Aleksandr Klepinin; Lyudmila Ounpuu; Rita Guzun; Vladimir Chekulayev; Natalja Timohhina; Kersti Tepp; Igor Shevchuk; Uwe Schlattner; Tuuli Kaambre
Journal:  J Bioenerg Biomembr       Date:  2016-11-17       Impact factor: 2.945

4.  Coenzyme q and the respiratory chain: coenzyme q pool and mitochondrial supercomplexes.

Authors:  José Antonio Enriquez; Giorgio Lenaz
Journal:  Mol Syndromol       Date:  2014-07

Review 5.  The role of tubulin in the mitochondrial metabolism and arrangement in muscle cells.

Authors:  Kersti Tepp; Kati Mado; Minna Varikmaa; Aleksandr Klepinin; Natalja Timohhina; Igor Shevchuk; Vladimir Chekulayev; Andrey V Kuznetsov; Rita Guzun; Tuuli Kaambre
Journal:  J Bioenerg Biomembr       Date:  2014-09-11       Impact factor: 2.945

Review 6.  Molecular and Supramolecular Structure of the Mitochondrial Oxidative Phosphorylation System: Implications for Pathology.

Authors:  Salvatore Nesci; Fabiana Trombetti; Alessandra Pagliarani; Vittoria Ventrella; Cristina Algieri; Gaia Tioli; Giorgio Lenaz
Journal:  Life (Basel)       Date:  2021-03-15

7.  Mitochondrial dysfunction in breast cancer cells prevents tumor growth: understanding chemoprevention with metformin.

Authors:  Rosa Sanchez-Alvarez; Ubaldo E Martinez-Outschoorn; Rebecca Lamb; James Hulit; Anthony Howell; Ricardo Gandara; Marina Sartini; Emanuel Rubin; Michael P Lisanti; Federica Sotgia
Journal:  Cell Cycle       Date:  2012-12-20       Impact factor: 4.534

8.  AG311, a small molecule inhibitor of complex I and hypoxia-induced HIF-1α stabilization.

Authors:  Anja Bastian; Satoshi Matsuzaki; Kenneth M Humphries; Gavin A Pharaoh; Arpit Doshi; Nilesh Zaware; Aleem Gangjee; Michael A Ihnat
Journal:  Cancer Lett       Date:  2016-12-08       Impact factor: 8.679

9.  Reverse Warburg Effect-Related Mitochondrial Activity and 18F-FDG Uptake in Invasive Ductal Carcinoma.

Authors:  Byung Wook Choi; Young Ju Jeong; Sung Hwan Park; Hoon Kyu Oh; Sungmin Kang
Journal:  Nucl Med Mol Imaging       Date:  2019-10-28

10.  Enhanced heme function and mitochondrial respiration promote the progression of lung cancer cells.

Authors:  Jagmohan Hooda; Daniela Cadinu; Md Maksudul Alam; Ajit Shah; Thai M Cao; Laura A Sullivan; Rolf Brekken; Li Zhang
Journal:  PLoS One       Date:  2013-05-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.